Nuveen Asset Management »

Skye Bioscience shares owned by Nuveen Asset Management

Quarter-by-quarter ownership of Skye Bioscience (SKYE) shares owned by Nuveen Asset Management from 13F filings

Historical chart of Nuveen Asset Management investment in Skye Bioscience

Tip: Access up to 7 years of quarterly data

All positions including Skye Bioscience held by Nuveen Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Skye Bioscience by Nuveen Asset Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $187k 23k 8.01

More positions owned by Nuveen Asset Management

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Alphabet Cap Stk Cl A (GOOGL)
Eli Lilly & Co. (LLY)
UnitedHealth (UNH)
Mastercard Incorporated Cl A (MA)
JPMorgan Chase & Co. (JPM)
Costco Wholesale Corporation (COST)
Nushares Etf Tr Get Opp Etf (NUGO)
Visa Com Cl A (V)

View all positions for Nuveen Asset Management

Top funds holding Skye Bioscience

5AM Venture Management
Versant Venture Management
Baker Bros. Advisors
Altium Capital Management
Logos Global Management
Sphera Funds Management
BlackRock
BlackRock
Schonfeld Strategic Advisors
Henderson Group
Ensign Peak Advisors
Vanguard Group
CVI Holdings
Driehaus Capital Management
Alyeska Investment Group

View all funds holding Skye Bioscience